NIOX Group Plc (AIM:NIOX)
London · Delayed Price · Currency is GBP · Price in GBX 68.60
-0.40 (-0.58%)
Jul 28, 2025, 4:35 PM GMT+1
NIOX Group Revenue
In the year 2024, NIOX Group had annual revenue of 41.80M GBP with 13.59% growth.
Revenue
41.80M
Revenue Growth
+17.09%
P/S Ratio
6.89
Revenue / Employee
459.34K
Employees
91
Market Cap
288.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.80M | 5.00M | 13.59% |
| Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
| Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
| Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
| Dec 31, 2020 | 23.90M | -10.70M | -30.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
NIOX Group News
- 3 months ago - Private equity firm withdraws takeover bid for NIOX Group - This is Money
- 4 months ago - AIM Market Roundup: Priority Intelligence, Niox, Coral Products - The Armchair Trader